)
)
ACELYRIN Investor Relations Material
Latest events
M&A Announcement
ACELYRIN
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from ACELYRIN INC
Access all reports
ACELYRIN, INC. is a Los Angeles area-based late-stage clinical biopharmaceutical company – with additional operations in the San Francisco Bay area – focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of promising drug candidates. ACELYRIN, INC. went public in May 2023.
Key slides for ACELYRIN INC
Corporate Presentation
ACELYRIN INC
Corporate Presentation
ACELYRIN INC
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
SLRN
Country
🇺🇸 United States